Who owns EVOKE PHARMA INC COM NEW?
- Ticker: EVOK
- CUSIP Number: 30049g203
Tip: Access positions for across all investors
Analyze quarterly positions in Evoke Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Evoke Pharma stock
Who bought or sold EVOKE PHARMA INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Altium Capital Management | 692k | $366k | -4% | Jun 2024 |
|
| Vanguard Group | 30k | $16k | 0% | Jun 2024 |
|
| State Street Corporation | 11k | $5.6k | 100% | Jun 2024 |
|
| Tower Research Capital | 7.5k | $4.0k | 1% | Jun 2024 |
|
| BlackRock | 1.5k | $774.016800 | 0% | Jun 2024 |
|
| Morgan Stanley | 375.00 | $198.000000 | 0% | Jun 2024 |
|
| Goss Wealth Management | 208.00 | $109.990400 | 0% | Jun 2024 |
|
Who sold out of Evoke Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AIGH Capital Management | Jun 2024 | 847k | $448k |
| Bleichroeder | Jun 2024 | 825k | $436k |
| Nantahala Capital Management | Jun 2024 | 675k | $357k |
| Geode Capital Management | Jun 2024 | 50k | $26k |
| Goldman Sachs Group | Mar 2024 | 14k | $8.2k |
| Citadel Advisors | Jun 2024 | 12k | $6.3k |